tiprankstipranks
Trending News
More News >
Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2)
:9G2
Singapore Market

Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Stock Statistics & Valuation Metrics

Compare
6 Followers

Total Valuation

Singapore Institute of Advanced Medicine Holdings Ltd. has a market cap or net worth of ―. The enterprise value is S$81.36M.
Market Cap
Enterprise ValueS$81.36M

Share Statistics

Singapore Institute of Advanced Medicine Holdings Ltd. has 1,062,020,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,062,020,600
Owned by Insiders
Owned by Institutions

Financial Efficiency

Singapore Institute of Advanced Medicine Holdings Ltd.’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -16.01%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-16.01%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee155.57K
Profits Per Employee-349.90K
Employee Count107
Asset Turnover0.12
Inventory Turnover12.51

Valuation Ratios

The current PE Ratio of Singapore Institute of Advanced Medicine Holdings Ltd. is -2.83. Singapore Institute of Advanced Medicine Holdings Ltd.’s PEG ratio is -0.05.
PE Ratio-2.83
PS Ratio0.00
PB Ratio0.45
Price to Fair Value1.29
Price to FCF-5.66
Price to Operating Cash Flow-5.60
PEG Ratio-0.05

Income Statement

In the last 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. had revenue of 16.65M and earned -37.45M in profits. Earnings per share was -0.04.
Revenue16.65M
Gross Profit15.36M
Operating Income-21.24M
Pretax Income-37.44M
Net Income-37.45M
EBITDA-13.42M
Earnings Per Share (EPS)-0.04

Cash Flow

In the last 12 months, operating cash flow was -5.61M and capital expenditures -21.80K, giving a free cash flow of -5.63M billion.
Operating Cash Flow-5.61M
Free Cash Flow-5.63M
Free Cash Flow per Share>-0.01

Dividends & Yields

Singapore Institute of Advanced Medicine Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.13
52-Week Price Change-70.00%
50-Day Moving Average0.03
200-Day Moving Average0.05
Relative Strength Index (RSI)35.56
Average Volume (3m)87.94K

Important Dates

Singapore Institute of Advanced Medicine Holdings Ltd. upcoming earnings date is Feb 14, 2025, During Market Hours (Confirmed).
Last Earnings DateOct 29, 2024
Next Earnings DateFeb 14, 2025
Ex-Dividend Date

Financial Position

Singapore Institute of Advanced Medicine Holdings Ltd. as a current ratio of 0.37, with Debt / Equity ratio of 79.35%
Current Ratio0.37
Quick Ratio0.36
Debt to Market Cap0.13
Net Debt to EBITDA-3.20
Interest Coverage Ratio-1.84

Taxes

In the past 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Singapore Institute of Advanced Medicine Holdings Ltd. EV to EBITDA ratio is -11.09, with an EV/FCF ratio of -10.06.
EV to Sales8.94
EV to EBITDA-11.09
EV to Free Cash Flow-10.06
EV to Operating Cash Flow-10.43

Balance Sheet

Singapore Institute of Advanced Medicine Holdings Ltd. has S$5.37M in cash and marketable securities with S$54.86M in debt, giving a net cash position of S$49.50M billion.
Cash & Marketable SecuritiesS$5.37M
Total DebtS$54.86M
Net CashS$49.50M
Net Cash Per ShareS$0.05
Tangible Book Value Per ShareS$0.08

Margins

Gross margin is -53.15%, with operating margin of -127.60%, and net profit margin of -224.95%.
Gross Margin-53.15%
Operating Margin-127.60%
Pretax Margin-224.91%
Net Profit Margin-224.95%
EBITDA Margin-80.60%
EBIT Margin-155.50%

Analyst Forecast

The average price target for Singapore Institute of Advanced Medicine Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target
Price Target Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score42.3
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis